HighGravityDataHumana — Jul 30, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000039
Showing in the filing
Effective Tax Rate
“GAAP: approximately 25.0%”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 24
GAAP EPS for FY2025
“approximately $13.77”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Individual Medicare Advantage membership (de… for FY2025
“up to 500,000 members”
CenterWell Primary Care FY 2025 net patient … for FY2025
“50,000 to 70,000”
Adjusted (non-GAAP) EPS for FY2025
“approximately $17.00”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $17.00”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $13.77”
Consolidated revenues for FY2025
“at least $128 billion”
Total Revenues Consolidated - GAAP for FY2025
“at least $128 billion”
Total Revenues - Insurance segment for FY2025
“GAAP: at least $123 billion”
Total Revenues - CenterWell segment for FY2025
“GAAP: at least $21.5 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of 'up to 500,000'”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth within 175,000 to 250,000 range”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results - Insurance segment income f… for FY2025
“$1.6 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“GAAP: $1.1 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“Non-GAAP: $1.3 billion to $1.7 billion”
Effective Tax Rate for FY2025
“GAAP: approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121 million”
Cash flows from operations for FY2025
“GAAP: $2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
CenterWell segment income from operations GAAP: $1.1 billion to $1.5 billion Non-GAAP: $1.3 billion to $1.7 billion GAAP: $1.0 billion to $1.5 billion Non-GAAP: $1.2 billion to $1.7 billion Effective Tax Rate no change GAAP: approximately 25.0% Weighted Avg. Share Count for Diluted EPS approximately 121 million approximately 121.5 million Cash flows from operations no change GAAP: $2.4 billion to $2.9 billion Capital expenditures no change approximately $650 million 13 Humana Inc. Statistical Schedules and Supplementary Information 2Q25 Earnings Release S-1 Humana Inc. Statistical Schedules and Supplementary Information 2Q25 Earnings Release (S-3) Summary of Results - Consolidated and Segments - Quarter & YTD (S-4) Consolidated Statements of Income - Quarter & YTD (S-5) Consolidated Balance Sheets (S-6) Consolidated Statements of Cash Flows - YTD (S-7) - (S-8) Consolidating Statements of Income - Quarter (S-9) - (S-10) Consolidating Statements of Income - YTD (S-11) Membership Detail (S-12) Premiums and Services Revenue Detail (S-13) - (S-15) CenterWell Segment - Pharmacy Solutions, Primary Care, & Home Solutions (S-16) Footnotes S-2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 2Q25 (a) 2Q24 (a) YTD 2025 (a) YTD 2024 (a) CONSOLIDATED Revenues $32,388 $29,540 $64,500 $59,151 Revenues - Adjusted (non-GAAP) $32,388 $29,380 $64,500 $58,711 Pretax results $741 $918 $2,432 $1,932 Pretax results - Ad
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.